August 9, 2021 Bio/Pharma/CRO PAI Top-10

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care

Pivotal phase III POLARIX trial comparing Polivy in combination with chemotherapy regimen R-CHP versus the standard of care R-CHOP in treatment of first-line diffuse large B-cell lymphoma (DLBCL) met its primary endpoint of investigator-assessed progression-free survival Prolonging survival without disease advancement could be transformative for newly diagnosed DLBCL patients as currently 40% of patients relapse... Read more

July 29, 2021 Bio/Pharma/CRO Informatics & Software M&A, Partnerships

Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process. July 29, 2021 Framingham, MA, USA and Basel, Switzerland — SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software... Read more

July 28, 2021 Bio/Pharma/CRO Chemicals, Reagents & Kits Clinical Research/Diagn. Lab Top-10 Product Launch

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

June 28, 2021 Bio/Pharma/CRO Chromatography M&A, Partnerships Mass Spectrometry

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

06/28/21 Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules NEWS SUMMARY: Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research. Projects include developing analytical workflows for nucleic acid therapeutic products and bioinformatics research to deliver robust and accurate identification for a variety of... Read more

June 22, 2021 Bio/Pharma/CRO Lab Top-10 M&A, Partnerships PAI Top-10

PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech

Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 22, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene... Read more

June 1, 2021 Bio/Pharma/CRO Lab Equipment M&A, Partnerships

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Changzhou, China, operations become Avantor’s first single-use production facility in AMEA region; doubles Avantor’s global single-use cleanroom space Adds proprietary technologies to Avantor’s bioprocessing manufacturing capabilities to meet growing global demand for single-use solutions RADNOR, Pa. and SHANGHAI, June 1, 2021 /PRNewswire/ —  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the... Read more

May 20, 2021 Bio/Pharma/CRO

Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning

Tecentriq improved disease-free survival by more than one-third in people with PD-L1-positive resectable early-stage lung cancer, compared with best supportive care First and only cancer immunotherapy to show positive Phase III results in the adjuvant lung cancer setting New adjuvant treatment options are urgently needed in early lung cancer to help the approximately 50% of... Read more

May 4, 2021 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and 908 Devices Announce Joint Collaboration

MAY 04, 2021 MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple... Read more

April 28, 2021 Acad, Gov/Utilities Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society WALTHAM, Mass. (April 28, 2021) — Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval... Read more